Literature DB >> 26536885

Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada.

Danna Hull1, Gregory Davies2,3, Christine M Armour4.   

Abstract

The purpose of this study was to explore the definition of fetal viability and the availability, indications, and decision making processes for post-viability termination of pregnancy for fetal abnormalities and health conditions in Canada. An online survey of members of the Canadian Association of Genetic Counsellors, the Canadian College of Medical Geneticists, and the Canadian Society for Maternal-Fetal Medicine who provide direct counselling to, or management of, prenatal patients in Canada (total sample size 815). Results of this study showed that the majority of respondents indicated that their centre will offer post-viability termination of pregnancy (98/123; 80 %). Sixty-seven percent (68/101) of respondents reported the definition of fetal viability to be 24 weeks' gestation. Most respondents reported that a collaborative decision making process was used to determine if post-viability termination of pregnancy would be offered (136/170; 80 %). For conditions presumed to be lethal/likely lethal, the majority of respondents would "sometimes" or "always" offer post-viability termination of pregnancy, whereas for conditions presumed to have a mild effect, the majority of respondents would "rarely" or "never" offer post-viability termination of pregnancy. Ninety percent (77/86) of respondents reported that perinatal hospice is offered as an alternative to termination of pregnancy. In conclusion, this study suggests that although post-viability termination is available in many provinces in Canada, variation in the definition of fetal viability and indications appear to exist. While these variations may lead to unequal access to post-viability termination of pregnancy across Canada, they might also represent the complexity of the decision making process and the importance of examining individual factors to ensure that the most appropriate decision is made in each case.

Entities:  

Keywords:  Late abortion; Post-viability; Termination of pregnancy; Viability

Mesh:

Year:  2015        PMID: 26536885     DOI: 10.1007/s10897-015-9907-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  7 in total

Review 1.  Perinatal hospice.

Authors:  N J Hoeldtke; B C Calhoun
Journal:  Am J Obstet Gynecol       Date:  2001-09       Impact factor: 8.661

Review 2.  A review of therapeutic abortions and related areas of concern in Canada.

Authors:  Jeanelle N Sabourin; Margaret Burnett
Journal:  J Obstet Gynaecol Can       Date:  2012-06

3.  Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres.

Authors:  Danna Hull; Gregory Davies; Christine M Armour
Journal:  J Obstet Gynaecol Can       Date:  2012-07

4.  Far from home? A pilot study tracking women's journeys to a Canadian abortion clinic.

Authors:  Christabelle Sethna; Marion Doull
Journal:  J Obstet Gynaecol Can       Date:  2007-08

5.  Counselling and management for anticipated extremely preterm birth.

Authors:  Ann L Jefferies; Haresh M Kirpalani
Journal:  Paediatr Child Health       Date:  2012-10       Impact factor: 2.253

6.  RETIRED: Canadian contraception consensus.

Authors:  Amanda Black; Diane Francoeur; Timothy Rowe; John Collins; Dianne Miller; Thomas Brown; Michèle David; Sheila Dunn; William A Fisher; Nathalie Fleming; Claude A Fortin; Edith Guilbert; Louise Hanvey; André Lalonde; Ruth Miller; Margaret Morris; Teresa O'Grady; Helen Pymar; Thirza Smith; Elke Henneberg
Journal:  J Obstet Gynaecol Can       Date:  2004-02

7.  RETIRED: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.

Authors:  Sylvie Langlois; Jo-Ann Brock
Journal:  J Obstet Gynaecol Can       Date:  2013-02
  7 in total
  2 in total

1.  Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists.

Authors:  Kym Boycott; Christine M Armour; Joanna Lazier; Taila Hartley; Jo-Ann Brock; Oana Caluseriu; David Chitayat; Anne-Marie Laberge; Sylvie Langlois; Julie Lauzon; Tanya N Nelson; Jillian Parboosingh; Dimitri J Stavropoulos
Journal:  J Med Genet       Date:  2021-09-20       Impact factor: 5.941

2.  Diagnosis of a severe congenital anomaly: A qualitative analysis of parental decision making and the implications for healthcare encounters.

Authors:  Robyn Lotto; Lucy K Smith; Natalie Armstrong
Journal:  Health Expect       Date:  2018-02-02       Impact factor: 3.377

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.